MT Newswires
Ovid Therapeutics Names Petra Kaufmann Chief Medical Officer
📊
AI Sentiment
Positive
6/10
- Home
- OVID
as of 12-08-2025 3:46pm EST
$1.59
$0.08
-4.79%
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
Chart Type:
Time Range:
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 117.3M | IPO Year: | 2017 |
| Target Price: | $3.60 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.50 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.24 - $2.01 | Next Earning Date: | 11-12-2025 |
| Revenue: | $6,610,000 | Revenue Growth: | 945.89% |
| Revenue Growth (this year): | 1077.56% | Revenue Growth (next year): | -97.44% |
AI-Powered OVID Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 70.95%
70.95%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Ovid Therapeutics Inc. News
OVID Breaking Stock News: Dive into OVID Ticker-Specific Updates for Smart Investing
GlobeNewswire
Ovid Therapeutics Appoints Dr. Petra Kaufmann as Chief Medical Officer
📈
AI Sentiment
Highly Positive
8/10
Compare OVID vs Leading Stocks
See how OVID stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "OVID Ovid Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.